MAPK phosphatases - Regulating the immune response

Nature Reviews Immunology

Volumn 7, Issue 3, 2007, Pages 202-212

  Liu, Yusen ^a   Shepherd, Edward G ^a   Nelin, Leif D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOMODULATING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTING CELL; CARBOXY TERMINAL SEQUENCE; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, NATURAL; INFECTION; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33847176551     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2035     Document Type: Review

References (111)

1. Johnson, G. L. & Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002).
2. Dong, C., Davis, R. J., & Flavell, R. A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72 (2002).
3. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 (2000).
4. Hanks, S. K. & Hunter, T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596 (1995).
5. Cobb, M. H. & Goldsmith, E. J. Dimerization in MAP-kinase signaling. Trends Biochem. Sci. 25, 7-9 (2000).
6. Davis, R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556 (1993).
7. Hazzalin, C. A. & Mahadevan, L. C. MAPK-regulated transcription: a continuously variable gene switch? Nature Rev. Mol. Cell Biol. 3, 30-40 (2002).
8. Ricci, R. et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306, 1558-1561 (2004).
9. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
10. Han, Z. et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 73-81 (2001).
11. Dumitru, C. D. et al. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083 (2000).
12. Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nature Cell Biol. 1, 94-97 (1999).
13. Jordan, J. D., Landau, E. M. & Iyengar, R. Signaling networks: the origins of cellular multitasking. Cell 103, 193-200 (2000).
14. Bhalla, U. S., Ram, P. T., & Iyengar, R. MAP kinase phosphatase as a locus of flexibility in a mitogenactivated protein kinase signaling network. Science 297, 1018-1023 (2002). This paper shows that the concentration of MKPs determines the bistable or monostable state of MAPKs.
15. Sun, H., Charles, C. H., Lau, L. F. & Tonks, N. K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493 (1993). This paper was the first to show that MKP1 serves as a phosphatase of MAPKs in vivo. This study is important, because it defined a new class of protein phosphatases. The authors proposed the concept that MKPs function as a feedback control mechanism for MAPK regulation.
16. Keyse, S. M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186-192 (2000).
17. Liu, Y., Gorospe, M., Yang, C. & Holbrook, N. J. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270, 8377-8380 (1995). This paper proposed for the first time that MKP1 functions as a phosphatase of JNK in the feedback control of gene expression in response to cellular stress.
18. Matsuguchi, T., Musikacharoen, T., Johnson, T. R., Kraft, A. S. & Yoshikai, Y. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 21, 6999-7009 (2001).
19. Mandl, M., Slack, D. N. & Keyse, S. M. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dualspecificity protein phosphatase DUSP5. Mol. Cell. Biol. 25, 1830-1845 (2005).
20. Wu, J. J., Zhang, L. & Bennett, A. M. The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation. Mol. Cell. Biol. 25, 4792-4803 (2005).
21. Karlsson, M., Mathers, J., Dickinson, R. J., Mandl, M. & Keyse, S. M. Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J. Biol. Chem. 279, 41882-41891 (2004).
22. Wu, J. J. et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab. 4, 61-73 (2006). This is the first paper to show that MKP1 has an important role in the regulation of metabolism.
23. Jeffrey, K. L. et al. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nature Immunol. 7, 274-283 (2006). This paper described Dusp2-/- mice and the alterations in immune-cell function and inflammatory responses found in these mice.
24. Brondello, J. M., Pouyssegur, J. & McKenzie, F. R. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514-2517 (1999). This paper was the first report to show that MKP protein stability can be regulated by MAPK-mediated phosphorylation.
25. 2-terminal kinase, induces phosphorylation and stabilization of MAPK phosphatase XCL100 in Xenopus oocytes. Mol. Biol. Cell 13, 454-468 (2002).
26. Katagiri, C. et al. Phosphorylation of Ser-446 determines stability of MKP-7. J. Biol. Chem. 280, 14716-14722 (2005).
27. Marchetti, S. et al. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol. Cell. Biol. 25, 854-864 (2005).
28. Camps, M. et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265 (1998). This paper was the first report to show that the catalytic activity of some MKPs can be influenced by interaction with their substrate MAPKs.
29. Stewart, A. E., Dowd, S., Keyse, S. M. & McDonald, N. Q. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nature Struct. Biol. 6, 174-181 (1999). This article described the crystal structure of the catalytic domain of MKP3. The authors proposed that catalytic activation of MKPs are mediated by the movement of the conserved aspartic acid residue closer to the catalytic site, and such conformational change allows the aspartic acid to function as a general acid.
30. Zhang, Y. et al. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430, 793-797 (2004). This paper was the first to show the physiological function of MKP5 in immune responses by using knockout mice.
31. -/- mice are profoundly sensitive to endotoxin.
32. Hammer, M. et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203, 15-20 (2006).
33. -/- mice are more sensitive to type II collagen-induced arthritis.
34. Chi, H. et al. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl Acad. Sci. USA 103, 2274-2279 (2006). In addition to the findings of references 31-34, this paper specifically shows that MKP1 is induced by TLR stimulation through pathways mediated by both MyD88 and TRIF.
35. Chen, P. et al. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide- stimulated macrophages. J. Immunol. 169, 6408-6416 (2002). This paper was the earliest report to show that MKP1 is a negative regulator of p38 and JNK in macrophages. It established the concept that MKP1 functions as a feedback control mechanism to restrain the production of pro-inflammatory cytokines, and that anti-inflammatory agents suppress the production of inflammatory cytokines through enhancing MKP1 expression.
36. -/- mice have no obvious phenotype.
37. Zhao, Q. et al. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 280, 8101-8108 (2005). This paper was the first report to show that MKP1 has a physiological role in the regulation of cytokine production using cells deficient in MKP1. It also showed that the relative anti-inflammatory potencies of synthetic corticosteroids are correlated with their abilities to induce MKP1 expression.
38. Howard, M., Muchamuel, T., Andrade, S. & Menon, S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208 (1993).
39. Gerard, C. et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550 (1993).
40. Hammer, M. et al. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur. J. Immunol. 35, 2991-3001 (2005). This paper showed that the expression of MKP1 is enhanced by the anti-inflammatory cytokine IL-10.
41. Shepherd, E. G. et al. The function of mitogenactivated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 279, 54023-54031 (2004). This was the first report to show that MKP1 has an important role in the host inflammatory response to TLR ligands other than LPS.
42. Philpott, D. J. & Girardin, S. E. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41, 1099-1108 (2004).
43. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999).
44. Yoshimura, A. et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1-5 (1999).
45. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
46. Tanoue, T., Adachi, M., Moriguchi, T., & Nishida, E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nature Cell Biol. 2, 110-116 (2000).
47. Hutter, D., Chen, P., Barnes, J. & Liu, Y. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem. J. 352 Pt 1, 155-163 (2000).
48. Nimah, M. et al. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock 23, 80-87 (2005). This paper was the first report to propose that MKP1 might have an important role in endotoxin tolerance.
49. Hu, J. H. et al. Feedback control of MKP-1 expression by p38. Cell Signal. 19, 393-400 (2007).
50. Theodosiou, A., Smith, A., Gillieron, C., Arkinstall, S. & Ashworth, A. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene 18, 6981-6988 (1999).
51. Tanoue, T., Moriguchi, T. & Nishida, E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 274, 19949-19956 (1999).
52. Rohan, P.J. et al. PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259, 1763-1766 (1993).
53. Chu, Y., Solski, P. A., Khosravi-Far, R., Der, C. J. & Kelly, K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271, 6497-6501 (1996). References 53 and 100 were the first reports to show that MKPs have distinct substrate specificities towards different members of the MAPK family. Reference 53 shows that DUSP2 prefers ERK and p38 as substrates.
54. Ward, Y. et al. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367, 651-654 (1994).
55. Tanoue, T., Yamamoto, T., Maeda, R. & Nishida, E. A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38α and β MAPKs. J. Biol. Chem. 276, 26629-26639 (2001).
56. Shen, Y. H. et al. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J. Biol. Chem. 278, 26715-26721 (2003).
57. Pages, G. et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374-1377 (1999).
58. H1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176, 5788-5796 (2006).
59. Nekrasova, T. et al. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis. J. Immunol. 175, 2374-2380 (2005).
60. Park, J. H. & Levitt, L. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-κB. Blood 82, 2470-2477 (1993).
61. Whitehurst, C. E. & Geppert, T. D. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156, 1020-1029 (1996).
62. Koike, T. et al. A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J. Biol. Chem. 278, 15685-15692 (2003).
63. H2 cells. Genes Funct. 1, 51-68 (1997).
64. Kurt, R. A., Urba, W. J., Smith, J. W. & Schoof, D. D. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int. J. Cancer 78, 16-20 (1998).
65. H1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17, 2817-2829 (1998).
66. Han, J., Thompson, P. & Beutler, B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/ tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172, 391-394 (1990).
67. Swantek, J. L., Cobb, M. H. & Geppert, T. D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17, 6274-6282 (1997).
68. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 10, 387-398 (1999).
69. Kassel, O. et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108-7116 (2001). This is the earliest report to show that glucocorticoids might exert their anti-inflammatory effects through the induction of MKP1.
70. Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J. & Clark, A. R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22, 7802-7811 (2002).
71. Abraham, S. M. et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883-1889 (2006). The paper showed that MKP1 is crucial for the anti-inflammatory activity of dexamethasone.
72. Eljaschewitsch, E. et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79 (2006). This paper showed an important role of MKP1 in neuronal protection by the endocannabinoid anandamide.
73. Burkart, V., Kim, Y., Kauer, M. & Kolb, H. Induction of tolerance in macrophages by cholera toxin B chain. Pathobiology 67, 314-317 (1999).
74. Burkart, V. et al. Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide. J. Immunol. 168, 1730-1737 (2002).
75. Sun, J. B., Rask, C., Olsson, T., Holmgren, J. & Czerkinsky, C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl Acad. Sci. USA 93, 7196-7201 (1996).
76. Bergerot, I. et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl Acad. Sci. USA 94, 4610-4614 (1997).
77. Tarkowski, A., Sun, J. B., Holmdahl, R., Holmgren, J. & Czerkinsky, C. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum. 42, 1628-1634 (1999).
78. Collart, M. A., Belin, D., Vassalli, J. D., de Kossodo, S. & Vassalli, P. γ interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164, 2113-2118 (1986).
79. Dileepan, K. N., Page, J. C., Li, Y. & Stechschulte, D. J. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-γ. J. Interferon Cytokine Res. 15, 387-394 (1995).
80. Meyer, K. C., Powers, C., Cornwell, R. & Borden, E. C. Priming of human alveolar macrophages and blood monocytes for superoxide anion release by interferons and lipopolysaccharide. J. Interferon Res. 11, 283-290 (1991).
81. Hayes, M. P., Enterline, J. C., Gerrard, T. L. & Zoon, K. C. Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production. J. Leukoc. Biol. 50, 176-181 (1991).
82. Calandra, T. & Roger, T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nature Rev. Immunol. 3, 791-800 (2003).
83. Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71 (1995).
84. Roger, T., Chanson, A. L., Knaup-Reymond, M. & Calandra, T. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur. J. Immunol. 35, 3405-3413 (2005). References 84 and 85 showed that MIF acts in an autocrine fashion to suppress glucocorticoidinduced MKP1 expression, thereby overriding the inhibition of cytokine production by glucocorticoids.
85. Aeberli, D. et al. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 580, 974-981 (2006).
86. 1 transition of cultured mouse cells. EMBO J. 4, 3145-3151 (1985).
87. Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000).
88. Wang, Z., Xu, J., Zhou, J. Y., Liu, Y. & Wu, G. S. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res. 66, 8870-8877 (2006). This paper provided evidence that MKP1 is involved in cellular resistance to chemotherapeutic drugs.
89. Vicent, S. et al. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin. Cancer Res. 10, 3639-3649 (2004).
90. Wang, H. Y., Cheng, Z. & Malbon, C. C. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett. 191, 229-237 (2003).
91. Denkert, C. et al. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int. J. Cancer 102, 507-513 (2002).
92. Liao, Q. et al. Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology 124, 1830-1845 (2003).
93. Charles, C. H., Abler, A. S. & Lau, L. F. cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 7, 187-190 (1992).
94. Keyse, S. M. & Emslie, E. A. Oxidative stress and heat shock induce a human gene encoding a proteintyrosine phosphatase. Nature 359, 644-647 (1992).
95. Kwak, S. P., Hakes, D. J., Martell, K. J. & Dixon, J. E. Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J. Biol. Chem. 269, 3596-3604 (1994).
96. Noguchi, T. et al. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol. Cell. Biol. 13, 5195-5205 (1993).
97. Franklin, C. C. & Kraft, A. S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272, 16917-16923 (1997). This was the first paper to show that MKP1 prefers p38 and JNK as substrates.
98. Guan, K. L. & Butch, E. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J. Biol. Chem. 270, 7197-7203 (1995).
99. King, A. G., Ozanne, B. W., Smythe, C. & Ashworth, A. Isolation and characterisation of a uniquely regulated threonine, tyrosine phosphatase (TYP 1) which inactivates ERK2 and p54jnk. Oncogene 11, 2553-2563 (1995).
100. Muda, M. et al. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271, 4319-4326 (1996).
101. Groom, L. A., Sneddon, A. A., Alessi, D. R., Dowd, S. & Keyse, S. M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15, 3621-3632 (1996).
102. Mourey, R. J. et al. A novel cytoplasmic dual specificity protein tyrosine phosphatase implicated in muscle and neuronal differentiation. J. Biol. Chem. 271, 3795-3802 (1996).
103. Muda, M. et al. Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J. Biol. Chem. 272, 5141-5151 (1997).
104. Dickinson, R. J. et al. Characterization of a murine gene encoding a developmentally regulated cytoplasmic dual-specificity mitogen-activated protein kinase phosphatase. Biochem. J. 364, 145-155 (2002).
105. Dowd, S., Sneddon, A. A. & Keyse, S. M. Isolation of the human genes encoding the Pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J. Cell Sci. 111, 3389-3399 (1998).
106. Shin, D. Y. et al. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction. Oncogene 14, 2633-2639 (1997).
107. Ishibashi, T., Bottaro, D. P., Michieli, P., Kelley, C. A. & Aaronson, S. A. A novel dual specificity phosphatase induced by serum stimulation and heat shock. J. Biol. Chem. 269, 29897-29902 (1994).
108. Martell, K. J., Seasholtz, A. F., Kwak, S. P., Clemens, K. K. & Dixon, J. E. HVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. J. Neurochem. 65, 1823-1833 (1995).
109. Theodosiou, A. M. et al. A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region. Hum. Mol. Genet. 5, 675-684 (1996).
110. Muda, M. et al. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208 (1996).
111. Spriggs, D. R., Deutsch, S. & Kufe, D. W. Genomic structure, induction, and production of TNF-α. Immunol. Ser. 56, 3-34 (1992).